[6] The most frequently reported adverse reactions-paranesthesia of the distal extremities, dysgeusia, somnolence, concentration difficulties, weight loss, and dizziness-occur in up to 40 % of patients during rapid titration but decline substantially with slower dose escalation and hydration
Pinching a small fold of skin and injecting into the lifted tissue, rather than pushing straight down into taut skin, creates a gentler angle for needle entry
Thus, whilst data linked to specific bone effects of these clinically approved drugs in humans is still evolving, the initial outlook is positive
However, repeatedly dosing early every week can alter your steady-state levels
Clinical trials such as the STEP programme (semaglutide) and SUSTAIN studies show that: Initial weeks : Modest weight loss primarily from reduced caloric intake Months 23 : More noticeable reduction becomes evident Months 36 : Continued steady weight loss as dose escalates Months 612 : Peak weight loss approaches, with most studies showing maximal effect by 1218 months It is important to recognise that GLP-1 medications require dose titration starting at a low dose and gradually increasing over several weeks according to the specific product's SmPC
Super-fast delivery Once you place your order, itll arrive within 3-5 business days